nCOP2 Vaccine              
Context:

• The World Health Organisation (WHO) has added a vaccine to its emergency listings. The added vaccine is the nCOP2 developed by BioFarm of Indonesia.
• The vaccine has been developed for the treatment of the derived poliovirus strain.

Key Highlights:

• This WHO approval is the first of its kind. According to the World Health Organisation, there have been a total of 149 poliovirus-derived immunodeficiency vaccines since May 2020.
• The vaccine was identified on the World Health Organisation Emergency Use List.
• The new Emergency Usage Listing System was established by the World Health Organisation in response to the Ebola virus epidemic that occurred between 2014 and 2016.